Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors
Leo Mascarenhas, Chitose Ogawa, Theodore W Laetsch, Brenda J Weigel, Michael W Bishop, Julie Krystal, Scott C Borinstein, Emily K Slotkin, Jodi A Muscal, Pooja Hingorani, Donna E Levy, Gary Mo, Ashwin Shahir, Jennifer Wright, Steven G DuBois
Dive into the research topics of 'Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors'. Together they form a unique fingerprint.